Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willy Gomm

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
JAMA Neurology|June 21, 2016
Proton Pump Inhibitors and Dementia Incidence-ReplyWilly Gomm, Britta Haenisch
Journal of Alzheimer'S Disease : JAD|March 17, 2025
Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016)Cornelia Becker, Lucas Herschung, Willy Gomm, et al.
BMC Public Health|February 8, 2025
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysisRoland Linder, Jonas Peltner, Anatoli Astvatsatourov, et al.
Journal of Alzheimer'S Disease : JAD|November 28, 2019
Glucocorticoid Therapy is Associated with a Lower Risk of DementiaMichael Nerius, Britta Haenisch, Willy Gomm, et al.
Mutation Research|April 15, 2008
Evaluation of the micronucleus assay in bone marrow and peripheral blood of rats for the determination of cigarette mainstream-smoke activityErik Van Miert, Patrick Vanscheeuwijck, Kris Meurrens, et al.
BMC Neurology|September 2, 2018
Hyperuricemia and dementia - a case-control studyBettina Engel, Willy Gomm, Karl Broich, et al.
Journal of the American Geriatrics Society|August 11, 2018
Reply to: Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance DataHeidi Taipale, Willy Gomm, Karl Broich, et al.
Regulatory Toxicology and Pharmacology : RTP|December 20, 2011
Discriminatory power of standard toxicity assays used to evaluate ingredients added to cigarettesMichael J Oldham, Hans-Juergen Haussmann, Willy Gomm, et al.
JAMA Neurology|February 17, 2016
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data AnalysisWilly Gomm, Klaus von Holt, Friederike Thomé, et al.
Deutsches Arzteblatt International|July 12, 2021
N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance DataWilly Gomm, Christoph Röthlein, Katrin Schüssel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
JAMA Neurology|June 21, 2016
Proton Pump Inhibitors and Dementia Incidence-ReplyWilly Gomm, Britta Haenisch
Journal of Alzheimer'S Disease : JAD|March 17, 2025
Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016)Cornelia Becker, Lucas Herschung, Willy Gomm, et al.
BMC Public Health|February 8, 2025
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysisRoland Linder, Jonas Peltner, Anatoli Astvatsatourov, et al.
Journal of Alzheimer'S Disease : JAD|November 28, 2019
Glucocorticoid Therapy is Associated with a Lower Risk of DementiaMichael Nerius, Britta Haenisch, Willy Gomm, et al.
Mutation Research|April 15, 2008
Evaluation of the micronucleus assay in bone marrow and peripheral blood of rats for the determination of cigarette mainstream-smoke activityErik Van Miert, Patrick Vanscheeuwijck, Kris Meurrens, et al.
BMC Neurology|September 2, 2018
Hyperuricemia and dementia - a case-control studyBettina Engel, Willy Gomm, Karl Broich, et al.
Journal of the American Geriatrics Society|August 11, 2018
Reply to: Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance DataHeidi Taipale, Willy Gomm, Karl Broich, et al.
Regulatory Toxicology and Pharmacology : RTP|December 20, 2011
Discriminatory power of standard toxicity assays used to evaluate ingredients added to cigarettesMichael J Oldham, Hans-Juergen Haussmann, Willy Gomm, et al.
JAMA Neurology|February 17, 2016
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data AnalysisWilly Gomm, Klaus von Holt, Friederike Thomé, et al.
Deutsches Arzteblatt International|July 12, 2021
N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance DataWilly Gomm, Christoph Röthlein, Katrin Schüssel, et al.
Pageof 2